论文信息 - Bevacizumab in age‐related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks - 字舞流文

Bevacizumab in age‐related macular degeneration: a randomized controlled trial on the effect of injections every 4 weeks, 6 weeks and 8 weeks

Sankha Amarakoon | T. Missotten | L. I. van den Born | G. Baarsma | José P. Martinez-Ciriano | Tanya Lushchyk | José P. Martinez‐Ciriano | G. Seerp Baarsma | Jose P Martinez-Ciriano